These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8984350)

  • 41. Nationwide surveillance of drug-resistant tuberculosis in The Netherlands: rates, risk factors and treatment outcome.
    Lambregts-van Weezenbeek CS; Jansen HM; Nagelkerke NJ; van Klingeren B; Veen J
    Int J Tuberc Lung Dis; 1998 Apr; 2(4):288-95. PubMed ID: 9559399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A high prevalence of culture-positive extrapulmonary tuberculosis in a large Dutch teaching hospital.
    Hesselink DA; Yoo SM; Verhoeven GT; Brouwers JW; Smit FJ; van Saase JL
    Neth J Med; 2003 Mar; 61(3):65-70. PubMed ID: 12765226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Current treatment of tuberculosis].
    Ramos Espinosa J; Méndez F
    Salud Publica Mex; 1982; 24(3):295-302. PubMed ID: 7147086
    [No Abstract]   [Full Text] [Related]  

  • 44. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Gupta R; Espinal MA; Raviglione MC
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):1089-91. PubMed ID: 11092726
    [No Abstract]   [Full Text] [Related]  

  • 45. Drug-resistant tuberculosis: controversies and challenges in pediatrics.
    Smith KC; Seaworth BJ
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):995-1010. PubMed ID: 16307511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Tuberculosis: reemerging disease].
    Fiaccadori F
    Ann Ital Med Int; 1996; 11(3):167-9. PubMed ID: 8998261
    [No Abstract]   [Full Text] [Related]  

  • 47. Antimicrobial resistance in tuberculosis: an international perspective.
    van Helden PD; Donald PR; Victor TC; Schaaf HS; Hoal EG; Walzl G; Warren RM
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):759-66. PubMed ID: 17140353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Multidrug-resistant tuberculosis. 4. Treatment and prognosis of multidrug-resistant tuberculosis].
    Ogawara M; Sakatani M
    Kekkaku; 1998 Nov; 73(11):673-7. PubMed ID: 9866930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemotherapy of tuberculosis.
    Tirumalachar MA
    P N G Med J; 1985 Jun; 28(2):89-91. PubMed ID: 3866438
    [No Abstract]   [Full Text] [Related]  

  • 50. Tuberculosis 2000-2010: control, but not elimination.
    Dye C
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S146-52. PubMed ID: 11144545
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Tuberculosis].
    Yoshiyama T
    Nihon Rinsho; 2001 Nov; 59 Suppl 7():189-96. PubMed ID: 11808120
    [No Abstract]   [Full Text] [Related]  

  • 52. Tuberculosis: current epidemiology and recommendations for treatment of TB infection.
    Taylor Z
    Ethn Dis; 2002; 12(1):S2-56-8. PubMed ID: 11913646
    [No Abstract]   [Full Text] [Related]  

  • 53. The threat of extensively drug-resistant tuberculosis.
    Mohapatra PR
    Clin Infect Dis; 2007 Mar; 44(6):888-9. PubMed ID: 17304469
    [No Abstract]   [Full Text] [Related]  

  • 54. [Characterization of 100 patients with tuberculosis treated in the Academic Medical Center in Amsterdam].
    Juffermans N; Verbon A; van der Meer JT; Dankert J; van Steenwijk RP; Speelman P
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):180-4. PubMed ID: 9557023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Current status of the chemotherapy of tuberculosis].
    Brändli O
    Schweiz Rundsch Med Prax; 1986 Nov; 75(47):1405-7. PubMed ID: 3797916
    [No Abstract]   [Full Text] [Related]  

  • 56. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Latent tuberculosis infection, its treatment, and the control and elimination of tuberculosis.
    Enarson DA
    Isr Med Assoc J; 2002 Jan; 4(1):31-2. PubMed ID: 11802307
    [No Abstract]   [Full Text] [Related]  

  • 58. TB treatment evolves.
    Huff B
    GMHC Treat Issues; 2003 Oct; 17(10):4-5. PubMed ID: 14689926
    [No Abstract]   [Full Text] [Related]  

  • 59. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antituberculosis drug resistance: practical solutions to practical problems.
    Tayler E
    J Med Microbiol; 1997 Jul; 46(7):531-3. PubMed ID: 9236735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.